Please Wait
Applying Filters...
menu
    • menu
    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Gusacitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 433,213Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sanofi Signs €545M Deal to Explore Formation’s JAK/SYK Inhibitor
    Sanofi Signs €545M Deal to Explore Formation’s JAK/SYK Inhibitor

    24 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/libertas-bio-a-formation-bio-subsidiary-license-of-gusacitinib-a-dual-jaksyk-inhibitor-to-sanofi-302487403.html

    PR NEWSWIRE
    24 Jun 2025
    Share Share
    Asana to Present Positive Results from Ph2b Study of Oral JAK/SYK Gusacitinib
    Asana to Present Positive Results from Ph2b Study of Oral JAK/SYK Gusacitinib

    20 Oct 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/asana-biosciences-to-present-positive-results-from-phase-2b-study-of-oral-jak-syk-inhibitor-gusacitinib-in-patients-with-chronic-hand-eczema-in-the-late-breaking-news-session-at-the-eadv-virtual-congress/

    BIOSPACE
    20 Oct 2020
    Share Share
    Asana BioSciences Announces Topline result Ph2b Study Oral JAK/SYK Gusacitinib
    Asana BioSciences Announces Topline result Ph2b Study Oral JAK/SYK Gusacitinib

    02 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200602005492/en

    BUSINESSWIRE
    02 Jun 2020
    Share Share
    Asana BioSciences Announces +ve Topline Results Ph2b Study Oral Gusacitinib
    Asana BioSciences Announces +ve Topline Results Ph2b Study Oral Gusacitinib

    02 Jun 2020

    // TYAHOO

    https://au.news.yahoo.com/asana-biosciences-announces-positive-topline-120000145.html

    TYAHOO
    02 Jun 2020
    Share Share